When comparing our findings with two larger cohorts of patients with MOG-EM, the German NEMOS cohort and Australasian/New Zealand MOG study group, preceding infections prior to first attack of MOG-EM were reported in 11/50 (22%; NEMOS) and 28/59 (47%; AUS) patients. The gene discussed is MOG; the disease is infection.